Montgomery Elmer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 W 3rd St, Kimberly, WI 54136 Phone: 920-788-7680 Fax: 920-788-7688 |
Sarah K Marcoe, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 W 3rd St, Kimberly, WI 54136 Phone: 920-788-7680 |
Ms. Katherine Nonweiler, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 W 3rd St, Kimberly, WI 54136 Phone: 920-788-7680 |
Dr. Rebecca Kristeen Doro, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 W 3rd St, Kimberly, WI 54136 Phone: 920-788-7680 Fax: 920-788-7688 |
Carolyn Blanc, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 W 3rd St, Kimberly, WI 54136 Phone: 920-788-7680 Fax: 920-788-7688 |
Joyce Bauer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 W 3rd St, Kimberly, WI 54136 Phone: 920-788-7680 Fax: 920-788-7688 |
News Archive
Promising data on MEK162 in an ongoing Phase 2 trial of patients with BRAF and NRAS mutated advanced melanoma was presented today at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has entered into an agreement allowing Eli Lilly and Company (NYSE: LLY) select access to research from its osteoarthritis genomic biomarker program
Since its launch in 2007, the Interactive Autism Network (IAN) has helped to accelerate the pace of autism research by gathering valuable information online from individuals on the autism spectrum and their parents. Today, the IAN Project launches the Grandparents of Children with Autism Spectrum Disorders Survey, giving grandparents a well-deserved voice in the autism research community.
Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).
› Verified 5 days ago